Ajay Ananda
Los Angeles, CANPI 1235113218
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Abbott accounts for 83.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $16,330 and has fallen 89.7% since, to $1,688 in 2025.
Across 362 payments — averaging $85.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$26K
- Boston Scientific$5K
- Medtronic$398
- Eisai Inc.$18
Across 4 payments — averaging $3400.39 each. An ownership or investment interest held by the physician or an immediate family member.
- Phasor Health, LLC$14K
What the payments were for
- Consulting fees$10,17333%
- Speaking & faculty fees$11,81338%
- Travel & lodging$2,5908%
- Food & beverage$6,34321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 50 | $25,797 |
| Boston Scientific | 297 | $4,704 |
| Medtronic(2 entities) | 14 | $398 |
| Eisai Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neuromodulation Dspsbls and Accs$16,114
- INFINITY$8,665
- GENERAL DBS$250
- Infinity DBS Pulse Generators$244
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.